glp 1 drugs kidney disease GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes New Guideline Puts Some at

By attenuating IR and lipotoxicity and enhancing metabolic stability, these agents provide a more controllable physiological substrate for subsequent reproductive interventions

Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T et al (2016) Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

Majzoub AM, Nayfeh T, Barnard A, Munaganuru N, Dave S, Singh S, et al

In fact, obesity treatment guidelines emphasize that GLP-1 medication should be combined with a high-protein diet, increased physical activity, and behavioral interventions (self-tracking, therapy, group support, dietary education, etc.)

1999;277:R582R590

and 8) alogliptin OR saxagliptin OR sitagliptin OR linagliptin OR vildagliptin